Showing results (1731-1740 of 3,475) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|December 26, 2022
Physiologically Based Pharmacokinetic Modelling to Identify Physiological and Drug Parameters Driving Pharmacokinetics in Obese IndividualsMattia Berton, Sara Bettonte, Felix Stader, et al.
Clinical Pharmacokinetics|December 29, 2022
Low and Highly Variable Exposure to Prophylactic LMWH Nadroparin in Critically Ill Patients: Back to the Drawing Board for Prophylactic Dosing?Jeroen Diepstraten, Anne van Rongen, Marianne P Zijlstra, et al.
Clinical Pharmacokinetics|June 14, 2022
A Review of Population Pharmacokinetic Analyses of LinezolidEnrique Bandín-Vilar, Laura García-Quintanilla, Ana Castro-Balado, et al.
Clinical Pharmacokinetics|June 6, 2022
Population Pharmacokinetics of Delamanid and its Main Metabolite DM-6705 in Drug-Resistant Tuberculosis Patients Receiving Delamanid Alone or Coadministered with BedaquilineLénaïg Tanneau, Mats O Karlsson, Andreas H Diacon, et al.
Clinical Pharmacokinetics|December 5, 2022
The Pharmacokinetics and Safety of Tucatinib in Volunteers with Hepatic ImpairmentAriel R Topletz-Erickson, Anthony J Lee, JoAl G Mayor, et al.
Clinical Pharmacokinetics|January 1, 1985
Comparison of drug dosing methodsM E Burton, M R Vasko, D C Brater
Clinical Pharmacokinetics|May 4, 2022
Determining the Effects of Chronic Kidney Disease on Organic Anion Transporter1/3 Activity Through Physiologically Based Pharmacokinetic ModelingSamuel Dubinsky, Paul Malik, Dagmar M Hajducek, et al.
Clinical Pharmacokinetics|May 20, 2019
A Comprehensive Whole-Body Physiologically Based Pharmacokinetic Model of Dabigatran Etexilate, Dabigatran and Dabigatran Glucuronide in Healthy Adults and Renally Impaired PatientsDaniel Moj, Hugo Maas, André Schaeftlein, et al.
Clinical Pharmacokinetics|May 22, 2019
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid GlycoproteinWai Hong Man, Ingeborg Wilting, Eibert R Heerdink, et al.
Clinical Pharmacokinetics|March 1, 1978
Clinical pharmacokinetics of rifampicinG Acocella
Pageof 348